肠道菌群与前列腺素关系的研究进展

晗 张, 洋 邓

摘要


肠道菌群是一个复杂的微生态系统,其种类、数量、比例、定位等要素的平衡对宿主健康产生重要影响,前列腺素一直以来被认为是重要的生理和炎性介质。 研究发现肠道菌群与前列腺素之间相互影响、共同作用。 本文从肠道菌群多样性对前列腺素浓度的影响、肠道菌群与前列腺素相互促进合成与转化等方面进行综述,为结肠癌的防治提供理论基础。

关键词


肠道菌群;前列腺素;结肠癌

全文:

PDF

参考


Gomez A, Petrzelkova K, Yeoman CJ, et al. Gut microbiome composition and metabolomic profiles of wild western lowland gorillas (Gorilla gorilla gorilla) reflect host ecology. Mol Ecol. 2015; 24 (10):2551-2565.

Honda K, Littman DR. The microbiome in infectious disease and inflammation[J]. Annu Rev Immunol,2012, 30:759-795.

Cani PD. Human gut microbiome: Hopes, threats and promises [J]. Gut,2018, 67:1716-1725.

Shen Z, Zhu C, Quan Y, et al. Update on intestinal microbiota in Crohn s disease 2017:Mechanisms,clinical application,adverse reactions, and outlook[J]. J Gastroenterol Hepatol,2017, 32 (11):1804-1812.

Frank DN, St AA, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases [J]. Proc Natl Acad Sci U S A, 2007, 104(34):13780-13785.

任巧盈,王香懿,李曜存, 等. 肠道菌群对代谢综合征影响的研 究进展[J]. 山东医药,2019, 59(14):112-114.

Lynch S V, Pedersen O. The human intestinal microbiome in health and disease[J]. New England Journal of Medicine, 2016, 375(24):2369-2379.

Zhang J, Gong Y, Yu Y. PG F2α receptor: a promising therapeutic target for cardiovascular disease. Front Phar- macol, 2010, 1:116

Narumiya S. Physiology and pathophysiology of prostanoid receptors. Proc Jpn Acad Ser B Phys Biol Sci. 2007, 83(9-10):296-319.

Schumacher Y, Aparicio T, Ourabah S, et al. Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth[ J]. Oncogene, 2016, 35( 20):2602-2614.

Loynes C A, Lee J A, Robertson A L, et al. PGE2 production at sites of tissue injury promotes an anti-inflammatory neutrophil phenotype and determines the outcome of inflammation resolution in vivo[J]. Science advances, 2018, 4(9): eaar8320.

Yao C, Sakata D, Esaki Y, et al. Prostaglandin E2-EP4 signaling promotes immune inflammation through TH1 cell differentiation and TH17 cell expansion [ J ]. Nature medicine, 2009, 15 (6): 633.

Funk CD. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-5.

Harris SG, Padilla J, Koumas L, et al. Prostaglandins as modulators of immunity. Trends Immunol 2002, 23:144-50.

Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-23.

Chen L, Wilson JE, Koenigsknecht MJ, et al. NLRP12 attenuates colon inflammation by maintaining colonic microbial diversity and promoting protective commensal bacterial growth. Nat Immunol 2017, 18:541-51.

O’Keefe SJ. Diet, microorganisms and their metabolites, and colon cancer. Nat Rev Gastroenterol Hepatol 2016, 13:691-706.

Plovier H, Cani PD. Microbial impact on host metabolism: opportunities for novel treatments of nutritional disorders? Microbiol Spectr 2017, 5(3).

Dubois RN. Role of inflammation and inflammatory mediators in colorectal cancer. Trans Am Clin Climatol Assoc 2014, 125: 358-72; discussion 372-3.

Dong L, Zou H, Yuan C, Hong YH, Kuklev DV, Smith WL. Different atty acids compete with arachidonic acid for binding to the allosteric or catalytic subunits of cyclooxygenases to regulate prostanoid synthesis[J]. Biol Chem 2016, 291:4069-78.




DOI: https://doi.org/10.36012/pmr.v2i6.2964

Refbacks

  • 当前没有refback。